High-risk prostate cancer treated with a stereotactic body radiation therapy boost following pelvic nodal irradiation

Overview of attention for article published in Frontiers in oncology, February 2024

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (72nd percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

So far, Altmetric has seen 10 X posts from 10 X users, with an upper bound of 31,295 followers.

RT @SbrtSean: High-risk prostate cancer treated with a stereotactic body radiation therapy boost following pelvic nodal irradiati… https://…

RT @SbrtSean: High-risk prostate cancer treated with a stereotactic body radiation therapy boost following pelvic nodal irradiati… https://…

RT @SbrtSean: High-risk prostate cancer treated with a stereotactic body radiation therapy boost following pelvic nodal irradiati… https://…

RT @SbrtSean: High-risk prostate cancer treated with a stereotactic body radiation therapy boost following pelvic nodal irradiati… https://…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 6 additional X posts.